Bilateral Scleromalacia Perforans in Rheumatoid Arthritis
Received Date: Nov 17, 2017 / Accepted Date: Nov 23, 2017 / Published Date: Nov 27, 2017
Scleromalacia perforans is a type of anterior necrotizing scleritis without inflammation resulting in progressive scleral thinning. This rare severe form of scleritis can be attributed to vasculitis, which may be a result of immune complex-mediated pathogenesis. Scleromalacia perforans can be idiopathic or secondary to other autoimmune diseases, including rheumatoid arthritis, Crohn’s disease, ulcerative colitis, vasculitis, and systemic lupus erythematosus.
Rheumatoid arthritis is a systemic disease with manifestations in many organs. Ophthalmic presentations include Sjogren’s syndrome, episcleritis, and scleritis. The most severe form of scleritis, scleromalacia perforans, is a very rare ophthalmic manifestation. We present the case of a 70-year-old female patient who had rheumatoid arthritis for more than 13 years. She had bilateral scleromalacia perforans but no other extra-articular manifestations. She complained of discomfort and mild pain in both eyes of 3 months duration.
Corrected visual acuity was 1/10, Sclera thinning in upper nasal quadrant with visible uveal tissue and no signs of inflammation was noted (Figure 1). Anterior chamber, iris and pupil were normal. Posterior subscapsular cataract was present. Applanation tension (intraocular pressure) was 12 mmHg.
Corrected visual acuity was 1/10. Scleral thinning with visible uveal tissue and no signs of inflammation was noted in upper temporal quadrant (Figure 2). Anterior chamber, iris and pupil were normal. Posterior subcapsular cataract was present. Applanation tension (intraocular pressure) was 13 mmHg. Fundus examination, after dilating the pupils did not show any abnormality in both eyes.
Conflict of Interest
The authors disclose no financial or proprietary conflicts of interest with this publication.
Citation: Chekhchar M, Arfaja A, Ajdakar S, Elghani Y, Hajji I, et al. (2017) Bilateral Scleromalacia Perforans in Rheumatoid Arthritis. Immunol Disord Immunother 2:116.
Copyright: © 2017 Chekhchar M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Theme: Novel Research and Therapeutic Challenges in Antibodies and Antibiotics
December 05-06, 2018 Chicago, USA
- Total views: 584
- [From(publication date): 0-2017 - Oct 21, 2018]
- Breakdown by view type
- HTML page views: 548
- PDF downloads: 36